BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18472015)

  • 21. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts.
    Hinchcliffe EH; Li C; Thompson EA; Maller JL; Sluder G
    Science; 1999 Feb; 283(5403):851-4. PubMed ID: 9933170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication.
    Duensing A; Liu Y; Tseng M; Malumbres M; Barbacid M; Duensing S
    Oncogene; 2006 May; 25(20):2943-9. PubMed ID: 16331279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of p53 and centrosome hyperamplification.
    Tarapore P; Fukasawa K
    Oncogene; 2002 Sep; 21(40):6234-40. PubMed ID: 12214254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of centrosome amplification after DNA damage depends on p27 accumulation.
    Sugihara E; Kanai M; Saito S; Nitta T; Toyoshima H; Nakayama K; Nakayama KI; Fukasawa K; Schwab M; Saya H; Miwa M
    Cancer Res; 2006 Apr; 66(8):4020-9. PubMed ID: 16618721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-step control of spindle pole body duplication by cyclin-dependent kinase.
    Haase SB; Winey M; Reed SI
    Nat Cell Biol; 2001 Jan; 3(1):38-42. PubMed ID: 11146624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.
    Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K
    Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication.
    Tarapore P; Okuda M; Fukasawa K
    Cell Cycle; 2002 Jan; 1(1):75-81. PubMed ID: 12429912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification.
    Hanashiro K; Brancaccio M; Fukasawa K
    Oncogene; 2011 May; 30(19):2188-97. PubMed ID: 21242972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing the degradation of mps1 at centrosomes is sufficient to cause centrosome reduplication in human cells.
    Kasbek C; Yang CH; Yusof AM; Chapman HM; Winey M; Fisk HA
    Mol Biol Cell; 2007 Nov; 18(11):4457-69. PubMed ID: 17804818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.
    Okuda M; Horn HF; Tarapore P; Tokuyama Y; Smulian AG; Chan PK; Knudsen ES; Hofmann IA; Snyder JD; Bove KE; Fukasawa K
    Cell; 2000 Sep; 103(1):127-40. PubMed ID: 11051553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1.
    Oikawa T; Okuda M; Ma Z; Goorha R; Tsujimoto H; Inokuma H; Fukasawa K
    Mol Cell Biol; 2005 May; 25(10):4046-61. PubMed ID: 15870277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nucleophosmin in centrosome duplication.
    Okuda M
    Oncogene; 2002 Sep; 21(40):6170-4. PubMed ID: 12214246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation.
    Minella AC; Swanger J; Bryant E; Welcker M; Hwang H; Clurman BE
    Curr Biol; 2002 Oct; 12(21):1817-27. PubMed ID: 12419181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrosomes, chromosome instability (CIN) and aneuploidy.
    Vitre BD; Cleveland DW
    Curr Opin Cell Biol; 2012 Dec; 24(6):809-15. PubMed ID: 23127609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of centrosomes in cells and their potential contribution to carcinogenesis].
    Białkowska A; Koczorowska AM; Kluzek K
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():1050-68. PubMed ID: 25228514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
    Lingle WL; Lukasiewicz K; Salisbury JL
    Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of E2F3 results in centrosome amplification.
    Saavedra HI; Maiti B; Timmers C; Altura R; Tokuyama Y; Fukasawa K; Leone G
    Cancer Cell; 2003 Apr; 3(4):333-46. PubMed ID: 12726860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centrosome amplification in tumorigenesis.
    Anderhub SJ; Krämer A; Maier B
    Cancer Lett; 2012 Sep; 322(1):8-17. PubMed ID: 22342684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centrosome amplification in CHO and DT40 cells by inactivation of cyclin-dependent kinases.
    Steere N; Wagner M; Beishir S; Smith E; Breslin L; Morrison CG; Hochegger H; Kuriyama R
    Cytoskeleton (Hoboken); 2011 Aug; 68(8):446-58. PubMed ID: 21766470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells.
    Diaz-Corrales FJ; Asanuma M; Miyazaki I; Miyoshi K; Hattori N; Ogawa N
    Neurotox Res; 2008 Dec; 14(4):295-305. PubMed ID: 19073433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.